Evaluating target-controlled infusion for anesthesia in heart surgery
Study on the Effect of Target-controlled Infusion of Propofol and Remifentanil for Patients Undergoing Cardiac Surgery
This study tests if a personalized anesthesia method can help heart surgery patients recover faster and have fewer complications after their operation.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Wuhan Union Hospital, China Academic / other |
| Locations | 1 site (Wuhan, Hubei) |
| Trial ID | NCT06012955 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the impact of individualized general anesthesia using target-controlled infusion (TCI) on postoperative outcomes in patients undergoing cardiac surgery. It focuses on whether TCI can facilitate earlier extubation and reduce postoperative complications. The study will observe patients aged 18 and older who are scheduled for cardiac surgery, monitoring their recovery and ventilation times. The effectiveness and safety of TCI in this context will be thoroughly evaluated.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are scheduled for cardiac surgery.
Not a fit: Patients who require mechanical ventilation support before surgery or are undergoing non-cardiac surgeries will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to faster recovery times and fewer complications for patients undergoing cardiac surgery.
How similar studies have performed: While this approach is being evaluated in this specific context, similar studies using target-controlled infusion in anesthesia have shown promising results in other surgical settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients aged 18 years and older who underwent cardiac surgery Exclusion Criteria: * Mechanical ventilation support before surgery; * Combined with any type of non-cardiac surgeries; * Second exploratory thoracotomy after surgery; * Died or discharged within 48 h after surgery; * Missing clinical data
Where this trial is running
Wuhan, Hubei
- Wuhan Union Hospital — Wuhan, Hubei, China (Recruiting)
Study contacts
- Study coordinator: Qingping Wu
- Email: wqp1968@163.com
- Phone: 13971605283
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.